Navigation Links
Boston Scientific Receives Industry's First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients
Date:2/22/2012

NATICK, Mass., Feb. 22, 2012 /PRNewswire/ -- Boston Scientific Corporation's (NYSE: BSX) ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System and TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent System have received U.S. Food and Drug Administration (FDA) approval for use in patients experiencing an acute myocardial infarction (AMI), or heart attack.  They are the only drug-eluting stent (DES) systems in the U.S. with an approved indication to treat patients with AMI.

The new indication, which accounts for approximately 10 percent of all coronary interventions, is a result of FDA review of data from the Paclitaxel (TAXUS) clinical program and HORIZONS-AMI trial.  In the global HORIZONS-AMI trial, 3,006 patients were randomized to receive either drug-eluting stents or bare-metal stents for the treatment of AMI, making it the largest randomized trial to study coronary stents in heart attack patients. 

"The AMI indication is a testament to our long-term commitment to innovation and leading clinical science in support of advanced DES technologies," said Keith D. Dawkins, M.D., Global Chief Medical Officer for Boston Scientific.  "Clinical data from the HORIZONS-AMI trial showed that, in patients with AMI, paclitaxel-eluting stents were superior in efficacy to bare-metal stents, significantly reducing clinical and angiographic restenosis compared to bare-metal stents, while demonstrating a comparable safety profile at three years.  We are proud that our investments in randomized trials such as HORIZONS-AMI have led to the approval of products to treat a broader range of patients with coronary artery disease."

"The new indication for heart attack patients should give U.S. physicians the confidence to treat this high-risk group with Boston Scientific's advanced paclitaxel-eluting stent technology backed by a ro
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... NORTH ANDOVER, Mass. , Aug. 26, 2014 ... and Eatontown, N.J ., is expanding.  ... & Fitness to form a new division, Acelleron Maternal Health ... to their clients by providing a full range of resources ... Vecchi has been named the director of maternal wellness. ...
(Date:8/26/2014)...  Royal Philips (NYSE: PHG, AEX: PHIA) introduces the ... to empower seniors to live independently while aging well. ... call center, the mobile app gives seniors 24-hour access ... Philips and the Global Social Enterprise Initiative (GSEI) ... 96 percent of senior respondents said it is important ...
(Date:8/26/2014)... 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: ... first patient into a phase II study to ... for the adjunctive treatment of major depressive disorder ... of a combination of deuterium modified dextromethorphan and ... of people with MDD who remain depressed despite ...
Breaking Medicine Technology:Suzanne Vecchi Named Director of Newly Acquired Acelleron Maternal Health & Wellness 2Philips Lifeline introduces response app to connect seniors with access to help in the event of an emergency 2Philips Lifeline introduces response app to connect seniors with access to help in the event of an emergency 3Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 2Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 3Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 4Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 5Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 6
... BEIJING , July 7 /PRNewswire-Asia-FirstCall/ -- Concord ... CCM ), operator of,the largest network of radiotherapy and ... has filed its annual report for the fiscal year ended, ... Securities and Exchange,Commission on June 30, 2010 . The ...
... HARBIN, China , July 6 /PRNewswire-Asia-FirstCall/ -- ... or the,"Company"), a leading developer, manufacturer and marketer of ... other,health and nutritional products in the People,s Republic ... the Global Hunter 2010 China Conference,on Tuesday, July ...
Cached Medicine Technology:Concord Medical Files 2009 Annual Report on Form 20-F 2Weikang Bio-Technology to Present at Global Hunter 2010 China Conference on July 13, 2010 2Weikang Bio-Technology to Present at Global Hunter 2010 China Conference on July 13, 2010 3
(Date:8/27/2014)... Helix House, an Internet marketing firm that ... record demand for marketing services that take advantage of ... the country and throughout Arizona looking for innovative and ... turning to experienced Internet marketing firms like Helix House. ... features a dedicated and organized team of Internet marketers ...
(Date:8/27/2014)... August 27, 2014 Hastings and Hastings, ... greater Phoenix metropolitan area and all of Arizona is ... $160,000 on a $2 million settlement. This is ongoing ... those who have been injured through no fault of ... and time-consuming, however Hastings and Hastings is unrelenting as ...
(Date:8/27/2014)... 2014 According to market research report, ... Power Range (Micro, Low, Medium, High), Voltage (Low & ... Geography - Global Market Trends & Forecast to 2019” ... with an analysis and forecast of the market size. ... estimated $16.64 billion in 2014 to $22.73 billion by ...
(Date:8/27/2014)... 2014 Specialty Technical Publishers (STP) and ... Audit Protocol Consortium (IAPC) EHS audit protocol for Brazil ... the world use IAPC EHS audit protocols to understand ... collect, share, archive, and export audit findings in a ... prepared by AECOM in partnership with STP and focus ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Main Street Dental ... announcing its advice on how long a toothbrush can be ... best oral care for teeth and gums. , “Replacing a ... fairly regular basis," says Dr. Harvey Schwartz, owner of Main ... every three to four months." , Dr. Schwartz explains that ...
Breaking Medicine News(10 mins):Health News:Helix House Reports Record Demand For Marketing Services That Take Advantage Of Social Media 2Health News:Helix House Reports Record Demand For Marketing Services That Take Advantage Of Social Media 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $166,700 On A Settlement Of $2,000,000 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $166,700 On A Settlement Of $2,000,000 3Health News:Variable Frequency Drives Market Worth $22.73 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Specialty Technical Publishers and AECOM Publish Environmental, Health & Safety (EHS) Audit Protocol for Brazil (and the State of São Paulo) 2Health News:Specialty Technical Publishers and AECOM Publish Environmental, Health & Safety (EHS) Audit Protocol for Brazil (and the State of São Paulo) 3Health News:Specialty Technical Publishers and AECOM Publish Environmental, Health & Safety (EHS) Audit Protocol for Brazil (and the State of São Paulo) 4Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Advises on the Best Time to Replace a Toothbrush 2
... 2007 According to a study using a dynamic ... NASDAQ: SHPGY, TSX: SHQ) ulcerative colitis drug LIALDA (mesalamine) ... drugs active ingredient, 5-aminosalicyclic acid (5-ASA), is released over ... colon is the site of inflammation in ulcerative colitis. ...
... Humans may not be any more sensitive in detecting ... recently published in Journal of Vision, an online, free-access ... Ophthalmology (ARVO). , Dr Eric Hiris of St. Mary,s ... that although many papers on the subject begin with ...
... assistance,division of Recovery Resources Inc., is offering Cleveland-area ... October in,recognition of national Drug-Free Work Week (October ... effective drug free workplace program. The U.S. ... in an,effort to educate businesses about the importance ...
... LONDON, October 17 - With Photo ... Around the,World, Raising Awareness of Stroke and Funds for ... plc, and James Cracknell OBE,double Olympic gold medallist, today ... Stroke Association. The campaign aims to,highlight the positive benefits ...
... offered to 10,000 Medicare Choice PPO members at no additional ... ... 17 Effective January 1, 2008, Group,Health Incorporated (GHI) has announced that ... toll-free number to speak with,their own independent Personal Health Advocate (PHA) for ...
... cancer ... awareness walk, WASHINGTON, Oct. 17 In an effort ... of,water and a storage unit during the Annual Walk for Hope to Cure ... 2K or 5K walk or run,took place at the grounds of Cabin John ...
Cached Medicine News:Health News:LIALDA demonstrates prolonged release of mesalamine in an in vitro study using a simulated colon 2Health News:LIALDA demonstrates prolonged release of mesalamine in an in vitro study using a simulated colon 3Health News:AssistNow Offers Area Employers Complimentary Needs Assessment in Recognition of National Drug-Free Work Week 2Health News:James Cracknell Launches Siemens Stroke for Stroke Week 2Health News:James Cracknell Launches Siemens Stroke for Stroke Week 3Health News:James Cracknell Launches Siemens Stroke for Stroke Week 4Health News:GHI to Provide Independent Personal Health Advocate for Medicare Members 2
... Seal-Away CS and Alliance Catheter ... for the introduction of catheters ... sinus from a superior approach. ... Medical's outstanding peel-away introducer performance ...
... been a key participant in the area ... a decade. Previous Medtronic autotransfusion systems allowed ... as well as to determine requirements for ... plasma (PRP) for a small amount of ...
This unique hemostatic seal provides a simple option for beating heart CABG anastomoses, allowing you to use your own hand-suturing technique without the release of cerebral emboli associated with th...
... .018 Biliary Self-Expanding Stent System combines low-profile, high ... This .018" guide wire compatible stent system provides ... all diameters (5.0 - 10.0 mm). Now, with ... offered in five stent lengths (28, 38, 56, ...
Medicine Products: